RxGen is a specialty translational research company devoted to understanding and overcoming human disease through innovative preclinical modeling. We apply significant preclinical and therapeutic domain expertise in ophthalmic, central nervous system, cardiovascular and metabolic disease to develop and apply translational models to meet the scientific needs of the global biomedical research community.